These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15949351)

  • 1. [The value of postoperative arterial infusion chemotherapy in patients with T3 esophageal squamous carcinoma after radical surgery].
    Liu BD; Zhi XY; Xu QS
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):586-9. PubMed ID: 15949351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
    Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
    Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
    Nakamori M; Iwahashi M; Nakamura M; Yamaue H
    J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.
    Ando N; Iizuka T; Ide H; Ishida K; Shinoda M; Nishimaki T; Takiyama W; Watanabe H; Isono K; Aoyama N; Makuuchi H; Tanaka O; Yamana H; Ikeuchi S; Kabuto T; Nagai K; Shimada Y; Kinjo Y; Fukuda H;
    J Clin Oncol; 2003 Dec; 21(24):4592-6. PubMed ID: 14673047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of postoperative chemotherapy after esophagectomy on the survival rate to patients with original squamous cell carcinoma of esophagus].
    Liu J; Wang YK; Liu Y; Zhang L; Chen JH; Zheng W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Apr; 25(4):346-50. PubMed ID: 15231207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of different extents of lymph node dissection on the survival in stage III esophageal cancer patients].
    Zhang GQ; Han F; Sun W; Pang ZL; SiKanDaer AB; Wang HJ
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):858-62. PubMed ID: 19173833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma].
    An FS; Huang JQ; Xie YT; Chen SH; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):376-9. PubMed ID: 12921571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).
    Ando N; Kato H; Igaki H; Shinoda M; Ozawa S; Shimizu H; Nakamura T; Yabusaki H; Aoyama N; Kurita A; Ikeda K; Kanda T; Tsujinaka T; Nakamura K; Fukuda H
    Ann Surg Oncol; 2012 Jan; 19(1):68-74. PubMed ID: 21879261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
    Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.
    Bédard EL; Inculet RI; Malthaner RA; Brecevic E; Vincent M; Dar R
    Cancer; 2001 Jun; 91(12):2423-30. PubMed ID: 11413534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meta-analysis of postoperative adjuvant chemotherapy for localized esophageal carcinoma].
    Huang WZ; Fu JH; Hu Y; Zhang X; Yang H
    Ai Zheng; 2006 Oct; 25(10):1303-6. PubMed ID: 17059782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.
    Shiozaki A; Yamagishi H; Itoi H; Fujiwara H; Kikuchi S; Okamoto K; Ichikawa D; Fuji N; Ochiai T; Sonoyama T; Ueda Y
    Oncol Rep; 2005 Apr; 13(4):667-72. PubMed ID: 15756440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma.
    Lu JC; Kong C; Tao H
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):710-4. PubMed ID: 20172661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report.
    Fujiwara Y; Kamikonya N; Inoue T; Koishi K; Yoshikawa R; Nakao K; Yagyu R; Nishiwaki M; Fujiwara M; Kojima S; Nakagawa K; Yamamura T
    Oncol Rep; 2005 Nov; 14(5):1177-82. PubMed ID: 16211282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
    Aroori S; Parshad R; Kapoor A; Gupta SD; Kumar A; Chattophadyay TK
    Indian J Cancer; 2004; 41(1):3-7. PubMed ID: 15105572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of low-dose cisplatin and 5-fluorouracil as adjuvant chemoradiotherapy for advanced squamous cell carcinoma of the esophagus.
    Shimizu K; Hihara J; Yoshida K; Toge T
    Hiroshima J Med Sci; 2005 Sep; 54(3):67-71. PubMed ID: 16180698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of the second cycle response to cisplatin-based chemotherapy as preoperative treatment for esophageal squamous cell carcinoma.
    Akita H; Doki Y; Miyata H; Hirao T; Yano M; Takachi K; Miyashiro I; Sasaki Y; Ishikawa O; Ohigashi H; Imaoka S
    J Surg Oncol; 2006 Apr; 93(5):401-9. PubMed ID: 16550577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
    Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
    Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.